^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-LeY- scFv-CD28-ζ vector

    i
    Other names: anti-LeY- scFv-CD28-ζ vector, anti-Lewis-Y chimeric antigen receptor, anti-LeY- scFv-CD28- zeta vector, LeY CAR T
    Associations

    News

    Trials
    Company:
    BMS, Peter MacCallum Cancer Centre
    Drug class:
    Lewis Y antigen-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    3ms
    A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours (clinicaltrials.gov)
    P1, N=20, Completed, Peter MacCallum Cancer Centre, Australia | Active, not recruiting --> Completed
    Trial completion • CAR T-Cell Therapy • Metastases
    |
    cyclophosphamide • anti-LeY- scFv-CD28-ζ vector